Global Coronavirus Vaccine Market to Surpass US$ 95,988 0 Million by 2028, Says Coherent Market Insights (CMI) einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Global mRNA Vaccines and Therapeutics Market: Focus on Application, mRNA Type, Country Data (13 Countries), and Competitive Landscape -.
:
The rising prevalence of urea cycle disorders is expected to increase the demand for treatment options for urea cycle disorders (UCD), which is expected to drive the growth of global urea cycle disorders treatment market during the forecast period. According to the Urea Cycle Disorders Consortium (UCDC), a part of the Rare Diseases Clinical Research Network (RDCRN), combined prevalence of urea cycle disorders is around 1 in 30,000 people in the U.S in 2017
Among regions, North America is expected to hold dominant position in the global urea cycle disorders treatment market during the forecast period, owing to key companies focusing on product launches for the treatment of Urea cycle disorders. For instance, in January 2021, Recordati Rare Diseases Inc. received the U.S. Food and Drug Administration (FDA) approval for CARBAGLU for the treatment of acute hyperammonemia.
WTO must revisit TRIPS to do away with patents on COVID vaccines as well as drugs
India is among several WTO members to demand patent waiver for vaccines, as have human rights bodies and global advocacy groups. However, there is strong lobbying by powerful pharmaceutical firms
The world needs more than COVID vaccine patent waivers
Engagement: 0
If the primary purpose of the World Trade Organization is âto open trade for the benefit of all,â it may be time for WTO to revisit its agreement on trade-related aspects of intellectual property rights (TRIPS) to do away with patents on COVID vaccines as well as drugs to hopefully save millions of lives across the world.